Alma Gregory Sorensen
Executive VP, Chief Strategy Officer & DirectorDr. Alma Gregory Sorensen, also known as Greg, is Director of SHINE Technologies LLC from July 2025. Dr. Sorensen serves Operating Advisor of Grovecourt Capital Partners from 2025. Dr. Sorensen served as Chief Science Officer until January 07, 2026 and is Chief Strategy Officer from January 07, 2026 and is Executive Vice President and Director at RadNet, Inc. since August 08, 2023. Dr. Sorensen has been Independent Member of Supervisory Board at Fresenius Medical Care AG since May 20, 2021. He has been Member of Supervisory Board at Fresenius Medical Care Management AG since May 20, 2021. He has been an Independent Director at DFP Healthcare Acquisitions Corp. since March 10, 2020. He has been an Executive Chairman of IMRIS, Inc. since February 3, 2016 and served as its Interim Chief Executive Officer from February 3, 2016 to February 22, 2016. He has served as the President and Chief Executive Officer of DeepHealth, Inc. since April 2017. He has served as the Chairman of Fusion Healthcare Staffing, LLC and a Member of the Board of Directors of Inviero LLC since December 2017. Dr. Sorensen is a neuroradiologist, well known in the industry for his innovative research in medical imaging and for his expertise in clinical practice. Before joining IMRIS, Dr. Sorensen served as the President and Chief Executive Officer of Siemens Healthcare North America from June 2011 to September 2015. Prior to Siemens, he served as Professor of Radiology and Health Sciences & Technology at Harvard Medical School; a faculty Member of the Harvard-MIT Division of Health Sciences and Technology; and Co-Director of the A. A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, as well as a visiting Professor of Neuroradiology at Oxford University. Leading up to his appointment with Siemens, Sorensen was a practicing neuroradiologist and active researcher with significant experience in clinical care, clinical trials and translational research. His research and techniques are utilized by numerous centers throughout the world in phase II and III trials in cancer, stroke and other illnesses. He has been a Director of DFB Healthcare Acquisitions Corp. since February 15, 2018. He has been a Director of IMRIS, Inc. since in October 2015. He had been Independent Member of Supervisory Board at Siemens Healthineers AG since March 01, 2018 until February 15, 2023. Dr. Sorensen holds a B. S. in Biology from California Institute of Technology, a M. S. in Computer Science from Brigham Young University, Provo, Utah and a Medical Degree from Harvard Medical School, Boston, Massachusetts from 1979 to 1989.
Positions
- Company NameRadNet, Inc.Stock CodeRDNTPositionExecutive VP, Chief Strategy Officer & DirectorColleagues
- HGHoward G. BergerChairman, President & CEO
- MDMark D. StolperExecutive VP & CFO
- MPMital PatelExecutive VP & COO
- NRNorman R. HamesPresident & CEO of Western Operations
- SMStephen M. ForthuberPresident & CEO of Eastern Operations
- DLDavid L. SwartzLead Independent Director
- LLLawrence L. LevittIndependent Director
- LPLaura Pastre JacobsIndependent Director
